Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023
Giuseppe Curigliano(University of Milan), Harold J. Burstein(Harvard University), Michael Gnant(Comprehensive Cancer Center Vienna), Sibylle Loibl(Cardiovascular Center Bethanien), David Cameron(NHS Lothian), Meredith M. Regan(Dana-Farber Cancer Institute), Carsten Denkert(Philipps University of Marburg), Philip Poortmans(University of Antwerp), William P. Weber(University of Basel), Beat Thürlimann(Sonnenhalde (Switzerland)), Stefan Aebi(Dana-Farber Cancer Institute), Meteb Al‐Foheidi(Sonnenhalde (Switzerland)), Fabrice André, Mykola Anikusko(Sonnenhalde (Switzerland)), R. Badwe(Dana-Farber Cancer Institute), A.V. Barrio, Carlos H. Barrios(Philipps University of Marburg), Jonas Bergh(Harvard University), Hervé Bonnefoi(Sonnenhalde (Switzerland)), Daniela Morales(Philipps University of Marburg), Sara Y. Brucker(Dana-Farber Cancer Institute), Harold J. Burstein(Harvard University), Carlos Caldas(Philipps University of Marburg), David Cameron(NHS Lothian), F. Cardoso, Maria João Cardoso, L.A Carey(Dana-Farber Cancer Institute), Stephen Chia(Dana-Farber Cancer Institute), Charlotte E. Coles(Philipps University of Marburg), J. Cortes(Harvard University), Giuseppe Curigliano(University of Milan), Jana de Boniface(Harvard University), Suzette Delaloge(Dana-Farber Cancer Institute), A. DeMichele, Carsten Denkert(Philipps University of Marburg), Gerd Fastner(Dana-Farber Cancer Institute), Florian Fitzal, Prudence A. Francis(University of Antwerp), H Gamal(Sonnenhalde (Switzerland)), Oreste Gentilini(Dana-Farber Cancer Institute), Michael Gnant(Comprehensive Cancer Center Vienna), William J. Gradishar(University of Basel), B. Gulluoglu(Sonnenhalde (Switzerland)), Nadia Harbeck(Dana-Farber Cancer Institute), Jörg Heil(Harvard University), Chien Shiun Huang, Jens Huober(Harvard University), Zeping Jiang, Orit Kaidar‐Person(Dana-Farber Cancer Institute), Marleen Kok(Sonnenhalde (Switzerland)), Eun‐So Lee, Sherene Loi(Cardiovascular Center Bethanien), S. Loibl(Cardiovascular Center Bethanien), Miguel Martín(Sonnenhalde (Switzerland)), Icro Meattini(Sonnenhalde (Switzerland)), Monica Morrow(Sonnenhalde (Switzerland)), A. H. Partridge, Frédérique Penault‐Llorca, Martine Piccart(Sonnenhalde (Switzerland)), Lori J. Pierce(Dana-Farber Cancer Institute), Philip Poortmans(University of Antwerp), Meredith M. Regan(Dana-Farber Cancer Institute), J. S. Reis-Filho(Harvard University), Isabel T. Rubio(Sonnenhalde (Switzerland)), Hope S. Rugo(Sonnenhalde (Switzerland)), Emiel J. Rutgers(Dana-Farber Cancer Institute), Cristina Saura(Philipps University of Marburg), Elżbieta Senkus(Dana-Farber Cancer Institute), Zhi-Ming Shao, Christian F. Singer(Philipps University of Marburg), Tanja Španič(Dana-Farber Cancer Institute), Beat Thuerlimann(Sonnenhalde (Switzerland)), Masakazu Toi(Sonnenhalde (Switzerland)), Sara M. Tolaney(Dana-Farber Cancer Institute), Nicholas C. Turner(Dana-Farber Cancer Institute), Andrew Tutt, M.-J. Vrancken Peeters, Toru Watanabe(Dana-Farber Cancer Institute), William P. Weber(University of Basel), Hans Wildiers(Sonnenhalde (Switzerland)), B. Xu(Sonnenhalde (Switzerland))
Cited by 211Open Access
Abstract
Related Papers
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
|The Lancet|2005|7.6k
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
Bernard Fisher, Joseph P. Costantino, D. Lawrence Wickerham et al.|JNCI Journal of the National Cancer Institute|1998|5.5k